Correlation Engine 2.0
Clear Search sequence regions


Sizes of these terms reflect their relevance to your search.

We report on a new concept for profiling genetic mutations of (lung) cancer cells, based on the detection of patterns of volatile organic compounds (VOCs) emitted from cell membranes, using an array of nanomaterial-based sensors. In this in-vitro pilot study we have derived a volatile fingerprint assay for representative genetic mutations in cancer cells that are known to be associated with targeted cancer therapy. Five VOCs were associated with the studied oncogenes, using complementary chemical analysis, and were discussed in terms of possible metabolic pathways. The reported approach could lead to the development of novel methods for guiding treatments, so that patients could benefit from safer, more timely and effective interventions that improve survival and quality of life while avoiding unnecessary invasive procedures. Studying clinical samples (tissue/blood/breath) will be required as next step in order to determine whether this cell-line study can be translated into a clinically useful tool. In this novel study, a new concept for profiling genetic mutations of (lung) cancer cells is described, based on the detection of patterns of volatile organic compounds emitted from cell membranes, using an array of nano-gold based sensors. Copyright © 2013 Elsevier Inc. All rights reserved.

Citation

Nir Peled, Orna Barash, Ulrike Tisch, Radu Ionescu, Yoav Y Broza, Maya Ilouze, Jane Mattei, Paul A Bunn, Fred R Hirsch, Hossam Haick. Volatile fingerprints of cancer specific genetic mutations. Nanomedicine : nanotechnology, biology, and medicine. 2013 Aug;9(6):758-66


PMID: 23428987

View Full Text